July 14, 2017
Notice Concerning Determination of Details of Issuance of Stock Options (Stock Acquisition Rights)ONO PHARMACEUTICAL CO., LTD. (Osaka, Japan; President, Representative Director and CEO, Gyo Sagara; "ONO") announced that the pending conditions of Stock Options (Stock Acquisition Rights) resolved at the meeting of Board of Directors held on June 29, 2017 have been determined today as set forth below.
Total number of the Stock Acquisition Rights: 29 (The number of shares issued per Stock Acquisition Right is 500)
Amount to be paid for the Stock Acquisition Rights:
883,000 yen per Stock Acquisition Right (1,766 yen per share)
Allottees and the number of Stock Acquisition Rights:
Allottees | Number | Number of Stock Acquisition Rights |
ONO's Directors (excluding outside directors) | 5 | 29 |
Corporate Communications public_relations@ono.co.jp
ONO Pharmaceutical Co. Ltd. published this content on 14 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 July 2017 09:34:06 UTC.
Original documenthttp://www.ono.co.jp/eng/news/pdf/sm_cn170714.pdf
Public permalinkhttp://www.publicnow.com/view/CEBCDA222C9682594D945FEDE3FA5BD95A467A0C